|
[1]
|
Effect of the Topical External Formulation of the Low-Affinity NMDA Receptor Antagonist Hemantane on Peripheral Sensitization Induced by TRPV1 Receptor Agonist Capsaicin in Mice
Pharmaceutical Chemistry Journal,
2022
DOI:10.1007/s11094-022-02550-0
|
|
|
|
|
[2]
|
The Role of a Dopaminergic Component in the Analgesic Effect of the Low-Affinity NMDA Receptor Antagonist Hemantane
Pharmaceutical Chemistry Journal,
2021
DOI:10.1007/s11094-021-02307-1
|
|
|
|
|
[3]
|
Comparative Assessment of the Effectiveness of Noncompetitive NMDA Receptor Antagonists Amantadine and Hemantane in Morphine Withdrawal Syndrome Model
Bulletin of Experimental Biology and Medicine,
2019
DOI:10.1007/s10517-019-04430-2
|
|
|
|
|
[4]
|
Comparative Evaluation of Antiparkinsonian, Anti-Inflammatory, and Analgesic Effects of Hemantane and Two 2-Aminoadamantane Derivatives Differing From it by a Bridgehead Hydroxyl
Pharmaceutical Chemistry Journal,
2019
DOI:10.1007/s11094-019-02009-9
|
|
|
|
|
[5]
|
Local Analgesic Activity of Hemantane Gel Dosage Forms Evaluated Using the Formalin Test in Rats
Pharmaceutical Chemistry Journal,
2018
DOI:10.1007/s11094-018-1890-6
|
|
|
|